Statin Use May Benefit Patients Hospitalized With COVID-19
The use of statins appears to benefit patients hospitalized with COVID-19, according to the findings of a retrospective study conducted in Hubei Province, China.
The use of statins appears to benefit patients hospitalized with COVID-19, according to the findings of a retrospective study conducted in Hubei Province, China.
Probiotics should only be recommended for specific patient populations since there is not enough evidence to support their use in the majority of digestive conditions, according to new clinical guidelines released by the American Gastroenterological Association (AGA) and recently published in Gastroenterology.
A recently published report describes the case of a 61-year-old male patient who experienced antacid-induced hypercalcemia and highlights the importance of performing thorough medication reconciliation.
After obtaining a more detailed history, it was discovered that the patient had been reusing insulin needles and was not rotating sites for insulin injection.
In order to provide national guidance addressing issues surrounding pain management practices, an expert panel was convened to provide a framework for pain practitioners and institutions.
Findings of the analysis also revealed that some evidence indicates that liraglutide improves liver fat, liver function, and HbA1c, and may aid in NASH resolution and weight reduction.